🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Sweden / NCT06773884
Enrolling by invitation Observational

Population-based Registry Study on Primary Hip Fracture Surgery

NCT06773884 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2024-12-01
Last updated
2025-01-14

Condition(s) studied

Hip Fracture

Investigational drug(s) / intervention(s)

"Observational Analysis of Primary Hip Fracture Surgery Outcomes"

"Observational Analysis of Primary Hip Fracture Surgery Outcomes": This study examines outcomes following standard primary hip fracture surgery by analyzing retrospective data from national health registries. The focus is on identifying perioperative and patient-related risk factors that influence outcomes such as reoperation rates, mortality, and secondary fractures within one year of surgery. No experimental or new intervention is introduced in this study.

Study summary

This study aims to describe primary hip fracture surgeries and to identify patient-related and perioperative risk factors affecting outcomes. It will utilize data from the Swedish Perioperative Registry (SPOR) and the Swedish National Patient Register to track epidemiological changes, treatment outcomes, and perioperative factors.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: \- Patients aged 18+ with hip fractures, identified through ICD code S72\*, who underwent surgery during the study period. Exclusion Criteria: * Patients without a Swedish personal identification number, as this is necessary to link data across registers.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universitetsjukhuset Örebro Sweden

More Region Örebro County trials in Sweden

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06773884 on ClinicalTrials.gov ↗ ← All trials in Sweden